As a common action of PTEN-knockout mice, Ipra treatment improved insulin resistance via its insulin-independent glucose-lowering action; indeed, the present study has shown that Ipra treatment improves both hyperglycemia and hyperinsulinemia with increased Akt phosphorylation in abdominal PVAT compared to vehicle treatment. Here, AKT1 is linked to Insulin resistance.